MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.6%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $113,302 | 82.86% |
ORACLE INVESTMENT MANAGEMENT INC | 152,600 | $5,513,438 | 4.06% |
Paradigm Biocapital Advisors LP | 1,443,762 | $52,163,121 | 4.03% |
Octagon Capital Advisors LP | 750,000 | $27,097,500 | 3.77% |
Boxer Capital, LLC | 2,000,000 | $72,260 | 3.35% |
RTW INVESTMENTS, LP | 4,472,985 | $161,608,948 | 3.08% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 260,000 | $9,393,800 | 2.86% |
Avoro Capital Advisors LLC | 5,555,555 | $200,722,202 | 2.72% |
Ghost Tree Capital, LLC | 200,000 | $7,226,000 | 2.38% |
Artal Group S.A. | 2,055,181 | $74,254 | 2.30% |
Camber Capital Management LP | 1,800,000 | $65,034 | 2.12% |
ARMISTICE CAPITAL, LLC | 3,978,000 | $143,725,140 | 2.08% |
5AM Venture Management, LLC | 192,500 | $6,955,025 | 1.73% |
SILVERARC CAPITAL MANAGEMENT, LLC | 150,000 | $5,419,500 | 1.68% |
SILVERARC CAPITAL MANAGEMENT, LLC | 91,213 | $3,295,526 | 1.02% |
Rock Springs Capital Management LP | 1,121,647 | $40,525,106 | 0.96% |
DAFNA Capital Management LLC | 94,700 | $3,421,511 | 0.94% |
SECTORAL ASSET MANAGEMENT INC | 148,553 | $5,367,220 | 0.90% |
Perceptive Advisors | 719,103 | $25,981,191 | 0.75% |
Orbimed Advisors | 913,650 | $33,010,175 | 0.60% |
External links
This page lists MIRATI THERAPEUTICS INC's shareholders in Q2 2023. To view MIRATI THERAPEUTICS INC's shareholder history, click here.